Bio-Rad Laboratories(NYSE) BIOB
| Metric | Price | Date |
|---|---|---|
| Last close | USD 309.37 | 2026-07-20 |
| Period | Price return | Price at period start | Period start date |
|---|---|---|---|
| 1 week | +0% | USD 309.37 | 2026-07-13 |
| 1 month | +1.72% | USD 304.15 | 2026-06-18 |
| 3 month | +11.69% | USD 277.00 | 2026-04-21 |
| Year to date | -0.43% | USD 310.70 | 2025-12-31 |
| 1 year | +20.03% | USD 257.75 | 2025-07-18 |
| 3 year | -20.17% | USD 387.55 | 2023-07-17 |
| 5 year | -54.18% | USD 675.25 | 2021-07-21 |
| Since inception | +12,701.69% | USD 2.42 | 1980-02-25 |
Bio-Rad Laboratories Financials at a Glance
Market Cap
Revenue (TTM)
Net Income (TTM)
EPS (TTM)
P/E Ratio
Dividend
Beta (Volatility)
Dividend
Beta (Volatility)
Price
Volume
Open
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
Dividend
Beta (Volatility)
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
BIOB News
Bio-Rad Completes AbD Serotec Purchase
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Rad Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareBIOB Financials
Key Financial Metrics (TTM)
Gross Margin
Operating Margin
Net Income Margin
Return on Equity
Return on Capital
Return on Assets
Earnings Yield
Payout Ratio
Stock Overview
Market Cap
Shares Outstanding
Volume
Avg. Volume
Financials (TTM)
Gross Profit
Operating Income
EBITDA
Operating Cash Flow
Capital Expenditure
Free Cash Flow
Cash & ST Invst.
Total Debt